Sort   by:  
 Page size 
ModelsHanson2016 - Toxicity Management in CAR T cell therapy for B-ALL
This model provides an in silico mathematical platform to explore the interactions between chimeric antigen receptor-modified T cells, inflammatory toxicitiy, and the tumour burdens of individual patients.
2024-09-02 | BIOMD0000000837 | BioModels
Immuno-oncology 
UnknownIrgm1 regulates metabolism and function in T cell subsets.
Not available
S-EPMC8763923 | biostudies-literature
UnknownPatient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901.
Not available
S-EPMC3413274 | biostudies-literature
UnknownAntigen receptor control of methionine metabolism in T cells.
Not available
S-EPMC6497464 | biostudies-literature
UnknownA comparison of institutional review board models and study efficiency in the Environmental influences on Child Health Outcomes Cohort Consortium.
Not available
S-EPMC12666723 | biostudies-literature
UnknownRhoptry and Dense Granule Secreted Effectors Regulate CD8+ T Cell Recognition of Toxoplasma gondii Infected Host Cells.
Not available
S-EPMC6742963 | biostudies-literature
UnknownmTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium.
Not available
S-EPMC5059740 | biostudies-literature
UnknownThe research equity and diversity initiative (READI): Changing the face of clinical research through community outreach and engagement.
Not available
S-EPMC12392350 | biostudies-literature
UnknownEvaluation of SARS-CoV-2 identification methods through surveillance of companion animals in SARS-CoV-2-positive homes in North Carolina, March to December 2020.
Not available
S-EPMC10607186 | biostudies-literature
UnknownNaive CD8 T cell IFNγ responses to a vacuolar antigen are regulated by an inflammasome-independent NLRP3 pathway and Toxoplasma gondii ROP5.
Not available
S-EPMC7480859 | biostudies-literature
Sort   by:  
 Page size